Does intrathecal morphine in the treatment of cancer pain induce the development of tolerance?

Neurosurgery

Volumn 42, Issue 1, 1998, Pages 44-50

  Sallerin Caute, Brigitte ^a   Lazorthes, Yves ^a,b   Deguine, Olivier ^a   Francés, Bernard ^a   Verdié, Jean Claude ^a   Charlet, Jean Paul ^a   Bastide, Raymond ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b CHU RANGUEIL   (France)

Author keywords

Cancer pain; Intrathecal administration; Morphine; Tolerance

Indexed keywords

MORPHINE;

ADULT; AGED; ANALGESIA; ARTICLE; CANCER PAIN; DRUG TOLERANCE; FEMALE; FOLLOW UP; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, SPINAL; LUMBOSACRAL REGION; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; PAIN, INTRACTABLE; PALLIATIVE CARE; RETROSPECTIVE STUDIES;

EID: 0031952322     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199801000-00009     Document Type: Article

References (39)

1. Basbaum AI: Insights into the development of opioid tolerance. Pain 61:349-352, 1995.
2. Bonica JJ: Treatment of cancer pain: Current status and future needs, in Fields HL, Dubner R, Cervero F (eds): Advances in Pain Research and Therapy. New York, Raven Press, 1985, vol 9, pp 589-616.
3. Brazenor GA: Long-term intrathecal administration of morphine: A comparison of bolus injection via reservoir with continuous infusion by implanted pump. Neurosurgery 21:484-491, 1987.
4. Chauvin M, Samii K, Schermann JM, Sandouk P, Bourbon R, Viars P: Plasma concentration after i.m., extradural and intrathecal administration. Br J Anaesth 53:911-913, 1981.
5. Cleary J, Backonja MM: "Translating" opioid tolerance research. Am Pain Soc Bull 5:4-7, 1996.
6. Colpaert FC: Can chronic pain be suppressed despite purported tolerance to narcotic analgesia? Life Sci 24:1201-1210, 1979.
7. Coombs DW: Intraspinal analgesic infusion by implanted pump. Ann N Y Acad Sci 531:108-122, 1988.
8. Crawford ME, Andersen HB, Augustenborg G, Bay J, Beck O, Benveniste D, Larsen LB, Carl P, Djernes M, Eriksen J, Grell AM, Henriksen H, Johansen SH, Jorgensen HOK, Moller IW, Pedersen JEP, Ravlo O: Pain treatment on out patient basis utilizing extradural opiates: A Danish multicenter study comprising 105 patients. Pain 16:41-17, 1983.
9. Detweiler DJ, Rohde DS, Basbaum AI: The development of opioid tolerance in the formalin test in the rat. Pain 63:251-254, 1995.
10. Foley KM: Pharmacological approaches to cancer pain management, in Fields HL, Dubner R, Cervero F (eds): Advances in Pain Research and Therapy. New York, Raven Press, 1985, vol 9, pp 629-653.
11. Foley KM: Controversies in cancer pain: Medical perspectives. Cancer 63:2257-2265, 1989.
12. Foley KM: Clinical tolerance to opioids, in Besson JM (ed): Towards a New Pharmacotherapy of Pain. New York, John Wiley & Sons, 1991, pp 181-203.
13. Foley KM: Changing concepts of tolerance to opioids: What the cancer patient has taught us, in Foley KM (ed): Current and Emerging Issues in Cancer Pain: Research and Practice. New York, Raven Press, 1993, pp 331-350.
14. Gouardères C, Jhamandas K, Cridland R, Cros J, Quirion R, Zajac JM: Opioid and substance P receptor adaptations in the rat spinal cord following sub-chronic intrathecal treatment with morphine and naloxone. Neuroscience 54:799-807, 1993.
15. Greenberg HS, Taren J, Ensminger WD, Doan K: Benefit from and tolerance to continuous intrathecal infusion of morphine for intractable cancer pain. J Neurosurg 57:360-364, 1982.
16. Gutstein HB, Trujillo KA, Akil H: Does chronic nociceptive stimulation alter the development of morphine tolerance? Brain Res 680:173-179, 1995.
17. Kayser V, Neil A, Guilbaud G: Repeated low doses of morphine induces a rapid tolerance in arthritic rats but a potentiation of opiate analgesia in normal animals. Brain Res 383:392-396, 1986.
18. Lazorthes Y, Sallerin B, Verdié JC, Bastide R: Advances in drug delivery systems and applications in neurosurgery, in Symon L (ed): Advances and Technical Standards in Neurosurgery. New York, Springer Verlag, 1991, vol 18, pp 143-192.
19. Lazorthes Y, Sallerin-Caute B, Verdié JC, Bastide R, Carillo JP: Chronic intrathecal Baclofen administration for control of severe spasticity. J Neurosurg 72:393-402, 1990.
20. Lazorthes Y, Verdié JC, Bastide R, Lavados A, Descouens D: Spinal versus intraventricular chronic opiate administration with implantable drug delivery devices for cancer pain. Appl Neurophysiol 48:234-241, 1985.
21. Mao J, Price DD, Mayer DJ: Mechanisms of hyperalgia and morphine tolerance: A current view of their possible interactions. Pain 62:259-274, 1995.
22. Milne B, Cervenko F, Jhamandas K, Loomis C, Sutak M: Analgesia and tolerance to intrathecal morphine and norepinephrine infusion via implanted mini-osmotic pumps in the rat. Pain 22: 165-172, 1985.
23. Neil A, Kayser V, Chen YL, Guilbaud G: Repeated low doses of morphine do not induce tolerance but increase the opioid antinociceptive effect in rat with a peripheral neuropathy. Brain Res 522:140-143, 1990.
24. Penn RD, Paice JA: Chronic intrathecal morphine for intractable pain. J Neurosurg 67:182-186, 1987.
25. Penn RD, Paice JA, Gotsschalk W, Ivankovich AD: Cancer pain relief using chronic morphine infusion: Early experience with a programmable implanted drug pump. J Neurosurg 61:302-306, 1984.
26. Portenoy RK: Cancer pain: Epidemiology and syndromes. Cancer 63:2298-2307, 1989.
27. Portenoy RK: Real patients, real problems: Optimal assessment and management of cancer pain - A monograph for continuing medical education credit.
28. Schug SA, Zech D, Grond S, Jung H, Meurser T, Stobbe B: A long-term survey of morphine in cancer pain patients. J Pain Symptom Manage 7:259-266, 1992.
29. Schultheiss R, Schramm J, Neidhardt J: Dose changes in long- and medium-term intrathecal morphine therapy of cancer pain. Neurosurgery 31:664-670, 1992.
30. Smart D, Lambert DG: The stimulatory effects of opioids and their possible role in the development of tolerance. Trends Pharmacol Sci 17:264-269, 1996.
31. Stein C, Millan MJ, Herz A: Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: Alterations in behavior and nociceptive thresholds. Pharmacol Biochem Behav 31:445-451, 1988.
32. Twycross RG: Opioid analgesics in cancer pain: Current practice and controversies. Cancer Surv 7:29-53, 1988.
33. Ventafridda V, Figliuzzi M, Tamburini M, Gori E, Parolaro D, Sala M: Clinical observation on analgesia elicited by intrathecal morphine in cancer patients, in Bonica JJ (ed): Advances in Pain Research and Therapy. New York, Raven Press, 1979, vol 3, pp 559-565.
34. Ventafridda V, Tamburini M, Caraceni A, DeConno F, Naldi F: A validation study of the WHO method for cancer pain relief. Cancer 59:850-856, 1987.
35. Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ: Physicians attitudes and practice in cancer pain management: A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 119:121-126, 1993.
36. Wang JK: Analgesic effect of intrathecally administered morphine. Reg Anesth 4:2-3, 1977.
37. Wiesenfeld Z, Gustafsson L: Continuous intrathecal administration of morphine via an osmotic minipump in the rat. Brain Res 247:195-197, 1982.
38. Yaksh TL: Spinal opiate analgesia: Characteristic and principles of actions. Pain 11:293-346, 1981.
39. Yaksh TL, Onofrio BM: Retrospective consideration of the doses of morphine given intrathecally by chronic infusion in 163 patients by 19 physicians. Pain 31:211-223, 1987.